• Slider Image
  • Slider Image
  • Slider Image

In the Press

June 25, 2019

California Protons Is Now Affiliated With UC San Diego Health Cancer Network

As of May 2019, California Protons Cancer Therapy Center is now affiliated with UC San Diego Health Cancer Network, giving more patients access to world-class, lifesaving proton therapy treatment provided by radiation oncologists from Moores Cancer Center at UC San Diego Health, San Diego’s only National Cancer Institute-Designated Comprehensive Cancer Center.

June 25, 2019

As state funding runs out, California stem cell scientists get $30 million gift

California stem cell researchers are getting $30 million to advance therapies for diseases of youth to old age under three grants from the Eli and Edythe Broad Foundation. They come when California’s $3 billion stem cell program, which has funded work from San Diego to Sacramento, is winding down.

June 23, 2019

How ‘Human on a Chip’ Technology Could Change the Way We Test Drugs

The new technology could eliminate the need for animal testing in many instances and has some profound implications for new cancer treatments, with Dr. Razelle Kurzrock weighing in.

June 18, 2019

Treatments on the Horizon for Cancers Linked to Epstein-Barr Virus

Initial results from clinical trials show new drug therapies are effective against lymphomas and other cancers connected to the Epstein-Barr virus, with lymphoma expert Dr. Erin Reid weighing in.

June 16, 2019

ONCTERNAL RETAINS CEO, WILL REMAIN IN SAN DIEGO: Reverse Merger To Support Co.’s Cancer Candidates

On the heels of auspicious clinical trial results, San Diego-based Oncternal Therapeutics completed a reverse merger with Tennessee’s GTx, it was announced June 10. Dr. Michael Choi, investigator in their CLL clinical trial gives insights into the combination study.

June 6, 2019

UCTV Launches New Stem Cell Channel

The new channel talked to Dr. Catriona Jamieson about how that information forms the basis for new leukemia therapies that she’s testing in clinical trials in our Alpha Stem Cell Clinic.

May 29, 2019

Dr. Cohen on the Era Before Immunotherapy in Head and Neck Cancer

Dr. Ezra Cohen discusses the treatment era before immunotherapy in head and neck cancer.

May 22, 2019

New study finds diet may reduce risk of breast cancer death

A new study shows that sticking to a low-fat, plant-based diet could reduce a woman’s risk of dying from breast cancer. Joining KUSI to discuss this study further is Dr. Anne Wallace.

May 22, 2019

The Top 25 Voices in Precision Medicine announced by BIS Research

Success in precision medicine has been largely dependent on thought leaders who are highly skilled interdisciplinary leaders, including Dr. Razelle Kurzrock.

May 21, 2019

Ignite San Diego: Local Business Spotlight of UC San Diego Moores Cancer Center

The industry relations department at UC San Diego Health’s Moores Cancer Center is tasked with translating UC San Diego faculty’s work into therapies, medical devices and other medical treatment, led by Dr. Ida Deichaite.

May 20, 2019

HEALTH: ARM OF MOORES CANCER CENTER HOLDS ANNUAL SYMPOSIUM: Office Bridges Gap Between Discovery, Therapeutics

UC San Diego Health’s Moores Cancer Center has an arm that’s charged with translating UC San Diego work into breakthrough therapies - led by Dr. Ida Deichaite. Reporter Jared Whitlock interviews Deichaite to learn about the symposium and groundbreaking oncology discoveries facilitated by our office.

May 15, 2019

Frontline Cancer: Knowledge is power; Leveraging genetic cancer predispositions

Cancer Center Director Dr. Scott Lippman explains our ability to discover inherited genetic differences that increase cancer risk, including site and type of cancer, has grown exponentially over the past few years, along with our understanding of the familial and genetic basis of cancer.

May 13, 2019

FDA will not ban textured implants that are linked to cancer

Dr. Anne Wallace, director of UC San Diego Health’s Comprehensive Breast Health Center joined Good Morning San Diego to discuss the Food and Drug Administration decision to decline to ban the sale of textured breast implants.

April 24, 2019

Exposing Cancer’s Metabolic Addictions

The article features research from senior authorDr. Paul Mischel: Real estate is important: where a tumor arises dictates specific metabolic vulnerabilities, identifying potential targets for effective cancer treatments.

April 22, 2019

Woman’s lethal cancer disappears after gene-matched therapy, leaving her in full remission

Near death, Teresa McKeown went into complete remission with lethal breast cancer, under the I-PREDICT trial, guided by her doctor and surgeon Dr. Jason Sicklick.

April 22, 2019

Personalizing Precision Medicine with Combination Therapies Improves Outcomes in Cancer

In a report, published online in Nature Medicine on April 22, 2019, senior authors Drs. Jason Sicklick and Razelle Kurzrock in partnership with lead investigator Dr. Shumei Kato, found that treating patients with personalized, combination therapies improved outcomes in patients with therapy resistant cancers.

April 22, 2019

Comprehensive Tumor Profiling Promises New Therapeutic Options for Patients with Advanced Cancer

Published in Nature Medicine today, results of WINTHER, the first study pioneered by the WIN Consortium, including investigator Dr. Razelle Kurzrock, shows that RNA profiling together with DNA testing matches more patients with advanced cancer to personalized therapies than DNA profiling for tumor mutations alone.

April 18, 2019

Nigeria nears clinical trials for stem cell therapies

The article features research from Dr. Dan Kaufman: after extensive preclinical testing, the US Food and Drug Administration (FDA) gave Dr. Kaufman and Fate Therapeutics the go-ahead last November to set up a phase I clinical trial to test their iPS-derived NK immunotherapy in people with advanced solid tumours.

April 12, 2019

Nigeria nears clinical trials for stem cell therapies

Fate Therapeutics begins experimental testing of ‘natural killer’ cells in cancer, working closely with expert Dr. Dan Kaufman. The first patient, Derek Ruff, was treated by Dr. Sandip Patel for his recurrent stage four colon cancer.

April 3, 2019

Family colon cancer risk similar for siblings and half siblings

Siblings of people with colorectal cancer are themselves at higher risk for the disease - but a new study suggests half-siblings face nearly as a high a risk. Joshua Demb, a researcher with the Moores Cancer Center at the University of California, San Diego and the San Diego Veterans Affairs Healthcare System comments on the study.

April 1, 2019

Federal Study Gives New Options for People With Rare Cancers

Rare cancers individually affect fewer than 6 in 100,000 people a year, but collectively make up 22% of all cancer cases. This study was led by Drs. Razelle Kurzrock and Sandip Patel.

» More Press

2019 Symposium

The 15th Moores Cancer Center Industry/Academia "Next Generation Precision Oncology" Symposium was held on Thursday, February 21, 2019. View the photo gallery for the highlights here.

Click to view full Agenda of the day:

2018 Symposium Featured Talks

The 14th Moores Cancer Center Industry/Academia Translational Oncology Symposium was held on Thursday, February 22, 2018. See the Agenda here.

Keynote Presentation: Duane Roth Award Lecture
Engineering T-Cells: The Sky is the Limit

Carl June, MD
University of Pennsylvania School of Medicine

Keynote Presentation:
A New Model for Translational Research in the Nonprofit Sector

Peter Schultz, PhD
California Institute for Biomedical Research

Welcome Remarks

Ida Deichaite, PhD, Symposium Organizer, UC San Diego Moores Cancer Center
Pradeep Khosla, PhD, Chancellor, UC San Diego

Welcome Remarks

Thomas Kipps, MD, PhD
Symposium Chair, UC San Diego Moores Cancer Center

In silico drug discovery of dual inhibitors of combinatorial synthetic lethality inhibitors in the era of prevision medical oncology; proof of concept

Donald Durden, MD, PhD
UC San Diego Moores Cancer Center

Visit our Symposium page for more Symposium Featured Talks.

2015 Symposium Slideshow

Thank you to all that came and participated in the 2015 Symposium - we hope you enjoy the memories!

2014 Translational Oncology Symposium

A decade of fostering collaborations, fueling innovation & saving lives

San Diego ABC 10 News reporter Michael Chen interviewed San Diego resident Heather Clark, a patient of Moores Cancer Center, along with Ida Deichaite, Director of Industry Relations & Symposium Organizer, in a video report about the I-SPY Clinical Trial and Symposium. The I-SPY Clinical Trial is lead by Symposium Keynote Speaker and Principle Investigator Laura Esserman, MD, MBA. For the video, see below.

The article is available here.

  • Xconomy’s San Diego Life Sciences Roundup included Bob Klein’s Proposal presented at the Moores Cancer Center Symposium, outlining the $5 billion ballot initiative for funding California Institute for Regenerative Medicine in 2016.
         » Read Here
  • Xconomy's San Diego Life Sciences Roundup also included the Moores Cancer Center Symposium and Laura Esserman's acceptance of the Duane Roth Award.
         » Read Here
  • The San Diego Daily Transcript published an article about Dr. Esserman's acceptance of the Duane Roth Award and the Symposium.
         » Read Here
  • The San Diego Union Tribune wrote an article on the Symposium, namely the iSPY Trial and patient from the trial, San Diego Resident Heather Clark.
         » Read Here
  • Symposium Speaker Bob Klein was featured in a San Diego Union Tribune article, outlining the $5 billion ballot initiative for funding California Institute for Regenerative Medicine in 2016, presented at the Moores Cancer Center Symposium.
         » Read Here

Our Symposium Page

9th Symposium Featured on San Diego ABC 10 News

San Diego ABC 10 News reporter Michael Chen interviewed San Diego resident Linda Lowe, a patient of Moores Cancer Center Investigator Dr. Catriona Jamieson, along with Moores Cancer Center Director of Industry Relations Ida Deichaite, PhD , in a video report from the 6PM News on April 11 covering the successful 9th Industry/Academia Translational Oncology Symposium.

More In the Press